Jean-Pierre Sommadossi Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jean-Pierre Sommadossi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jean-Pierre Sommadossi. Jean-Pierre Sommadossi is President, CEO, Chairman in IDENIX PHARMACEUTICALS INC ($IDIX) and President, CEO, and Chairman in Atea Pharmaceuticals, Inc. ($AVIR) and Director in Kezar Life Sciences, Inc. ($KZR).
Latest Insider Trading Transactions of Jean-Pierre Sommadossi
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVIR, IDIX, KZR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 01 2021 | AVIR | Atea Pharmaceutica ... | Sommadossi Jean-Pierre | President, CEO, and ... | Option Exercise | A | 73.00 | 640,000 | 46,720,000 | 640,000 | |
| Jun 26 2020 | KZR | Kezar Life Science ... | Sommadossi Jean-Pierre | Director | Option Exercise | A | 5.60 | 8,896 | 49,818 | 8,896 | |
| Jun 27 2019 | KZR | Kezar Life Science ... | Sommadossi Jean-Pierre | Director | Option Exercise | A | 7.63 | 8,896 | 67,876 | 8,896 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Sommadossi Jean-Pierre | Director | Option Exercise | C | 0.00 | 35,258 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Sommadossi Jean-Pierre | Director | Option Exercise | C | 0.00 | 52,581 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Sommadossi Jean-Pierre | Director | Buy | C | 0.00 | 35,258 | 0 | 178,440 | 143.2 K to 178.4 K (+24.62 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Sommadossi Jean-Pierre | Director | Buy | C | 0.00 | 52,581 | 0 | 143,182 | 90.6 K to 143.2 K (+58.04 %) |
| Mar 02 2005 | IDIX | IDENIX PHARMACEUTI ... | Sommadossi Jean-Pierre | President, CEO, Cha ... | Option Exercise | A | 19.14 | 150,000 | 2,871,000 | 150,000 | |
| Aug 30 2004 | IDIX | IDENIX PHARMACEUTI ... | Sommadossi Jean-Pierre | President, CEO, Cha ... | Option Exercise | M | 8.50 | 43,750 | 371,875 | 56,250 | |
| Aug 30 2004 | IDIX | IDENIX PHARMACEUTI ... | Sommadossi Jean-Pierre | President, CEO, Cha ... | Buy | M | 8.50 | 43,750 | 371,875 | 2,007,614 | 2 M to 2 M (+2.23 %) |
| Jul 29 2004 | IDIX | IDENIX PHARMACEUTI ... | Sommadossi Jean-Pierre | President, CEO, Cha ... | Option Exercise | A | 12.05 | 100,000 | 1,205,000 | 100,000 | |
| Jul 29 2004 | IDIX | IDENIX PHARMACEUTI ... | Sommadossi Jean-Pierre | President, CEO, Cha ... | Buy | P | 14.00 | 6,364 | 89,096 | 1,963,864 | 2 M to 2 M (+0.33 %) |
Page: 1